These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 27567868)
21. Active immunization of mice with an Abeta-Hsp70 vaccine. Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970 [TBL] [Abstract][Full Text] [Related]
22. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry. Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542 [TBL] [Abstract][Full Text] [Related]
23. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Geula C; Wu CK; Saroff D; Lorenzo A; Yuan M; Yankner BA Nat Med; 1998 Jul; 4(7):827-31. PubMed ID: 9662375 [TBL] [Abstract][Full Text] [Related]
24. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478 [TBL] [Abstract][Full Text] [Related]
25. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation. Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077 [TBL] [Abstract][Full Text] [Related]
26. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity. Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517 [TBL] [Abstract][Full Text] [Related]
27. Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease. Fukuchi K; Tahara K; Kim HD; Maxwell JA; Lewis TL; Accavitti-Loper MA; Kim H; Ponnazhagan S; Lalonde R Neurobiol Dis; 2006 Sep; 23(3):502-11. PubMed ID: 16766200 [TBL] [Abstract][Full Text] [Related]
28. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556 [TBL] [Abstract][Full Text] [Related]
29. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Mueller-Steiner S; Zhou Y; Arai H; Roberson ED; Sun B; Chen J; Wang X; Yu G; Esposito L; Mucke L; Gan L Neuron; 2006 Sep; 51(6):703-14. PubMed ID: 16982417 [TBL] [Abstract][Full Text] [Related]
30. beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology. Vehmas AK; Borchelt DR; Price DL; McCarthy D; Wills-Karp M; Peper MJ; Rudow G; Luyinbazi J; Siew LT; Troncoso JC DNA Cell Biol; 2001 Nov; 20(11):713-21. PubMed ID: 11788049 [TBL] [Abstract][Full Text] [Related]
32. Assessment of non-viral amyloid-β DNA vaccines on amyloid-β reduction and safety in rhesus monkeys. Tokita Y; Kaji K; Lu J; Okura Y; Kohyama K; Matsumoto Y J Alzheimers Dis; 2010; 22(4):1351-61. PubMed ID: 20930304 [TBL] [Abstract][Full Text] [Related]
33. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization. Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878 [TBL] [Abstract][Full Text] [Related]
35. An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect. Liu YH; Bu XL; Liang CR; Wang YR; Zhang T; Jiao SS; Zeng F; Yao XQ; Zhou HD; Deng J; Wang YJ J Neuroinflammation; 2015 Aug; 12():153. PubMed ID: 26311039 [TBL] [Abstract][Full Text] [Related]
37. An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice. Frost JL; Liu B; Rahfeld JU; Kleinschmidt M; O'Nuallain B; Le KX; Lues I; Caldarone BJ; Schilling S; Demuth HU; Lemere CA Neurobiol Aging; 2015 Dec; 36(12):3187-3199. PubMed ID: 26453001 [TBL] [Abstract][Full Text] [Related]
38. A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's disease. Wang SW; Liu DQ; Zhang LX; Ji M; Zhang YX; Dong QX; Liu SY; Xie XX; Liu RT Alzheimers Res Ther; 2017 Jun; 9(1):41. PubMed ID: 28592267 [TBL] [Abstract][Full Text] [Related]
39. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease. Bi Oh S; Suh N; Kim I; Lee JY Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795 [TBL] [Abstract][Full Text] [Related]